Original ArticlesClinical Immunology and Pathology

Glomerular Pathology in Dent Disease and Its Association with Kidney Function

Xiangling Wang, Franca Anglani, Lada Beara-Lasic, Anila J. Mehta, Lisa E. Vaughan, Loren Herrera Hernandez, Andrea Cogal, Steven J. Scheinman, Gema Ariceta, Robert Isom, Lawrence Copelovitch, Felicity T. Enders, Dorella Del Prete, Giuseppe Vezzoli, Fabio Paglialonga, Peter C. Harris and John C. Lieske
CJASN December 2016, 11 (12) 2168-2176; DOI: https://doi.org/10.2215/CJN.03710416

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Background and objectives Dent disease is a rare X–linked disorder characterized by low molecular weight proteinuria and often considered a renal tubular disease. However, glomerulosclerosis was recently reported in several patients. Thus, Dent disease renal histopathologic features were characterized and assessed, and their association with kidney function was assessed.

Design, setting, participants, & measurements Clinical renal pathology reports and slides (where available) were collected from 30 boys and men in eight countries who had undergone clinical renal biopsy between 1995 and 2014.

Results Median (25th, 75th percentiles) age at biopsy was 7.5 (5, 19) years with an eGFR of 69 (44, 94) ml/min per 1.73 m2 and a 24-hour urine protein of 2000 (1325, 2936) mg. A repeat biopsy for steroid-resistant proteinuria was performed in 13% (four of 30) of the patients. Prominent histologic findings included focal global glomerulosclerosis in 83% (25 of 30; affecting 16%±19% glomeruli), mild segmental foot process effacement in 57% (13 of 23), focal interstitial fibrosis in 60% (18 of 30), interstitial lymphocytic infiltration in 53% (16 of 30), and tubular damage in 70% (21 of 30). Higher percentages of globally sclerotic glomeruli, foot process effacement, and interstitial inflammation were associated with lower eGFR at biopsy, whereas foot process effacement was associated with steeper annual eGFR decline.

Conclusions These associations suggest a potential role for glomerular pathology, specifically involving the podocyte, in disease progression, which deserves further study. Furthermore, Dent disease should be suspected in boys and men who have unexplained proteinuria with focal global glomerulosclerosis and segmental foot process effacement on renal biopsy.

Introduction

Dent disease is a rare X–linked inherited disorder first described in 1964 (1) that is characterized by low molecular weight proteinuria (LMWP) and hypercalciuria (2,3). Mutations in CLCN5 account for approximately 60% of patients (Dent disease 1; OMIM300009), whereas mutations in OCRL1 account for approximately 15% (Dent disease 2; OMIM300555); another 25% of patients lack molecular genetic characterization (2,4). Patients often develop nephrocalcinosis, kidney stones or CKD, but the phenotype of Dent disease varies, which can make diagnosis difficult (4,5). Increased LMWP (e.g., retinol binding protein, α1-microglobulin, and β2-microglobulin), typically 10-fold normal, is characteristic (2). However, because LMWP is not routinely measured and the phenotype can overlap with other causes of proteinuric CKD and/or urinary stone disease (6), the disease is likely underdiagnosed or diagnosed late after patients have failed an immune suppression regimen.

Dent disease has largely been considered a disease of the tubules (7), although glomerulosclerosis was also described (7,8). Early studies revealed that CLC-5, encoded by the CLCN5 gene, was expressed in the proximal tubules, thick ascending limbs of the Henle loop, and collecting ducts, thus explaining certain features of the phenotype, such as LMWP (9). A recent study documented that ClC-5 is also expressed in human podocytes, and ClC-5 overexpression was detected in biopsies of certain proteinuric patients without Dent disease (10). However, the physiologic function of CLC-5 in podocytes is not known, and also, the consequences of its absence are not known. Furthermore, small case series of patients with CLCN5 mutations, focal global glomerulosclerosis, and varying degrees of hypercalciuria have recently been reported (11,12). Thus, glomerular pathology may be more common than previously recognized in Dent disease. Hence, in this study, we characterized Dent disease renal histopathologic features in a larger cohort and their association with kidney function.

Materials and Methods

Study Population

This study was approved by the Mayo Clinic Institutional Review Board and the Ethics Committee for experimental studies of Azienda Ospedaliera of Padovain, Italy. The Rare Kidney Stone Consortium (RKSC) Registry data were reviewed to identify patients with Dent disease and previous clinical kidney biopsies. These patients were sent a letter inviting participation in this study. After informed consent, their official pathologic reports and original slides (if available) were obtained for review. Other patients with Dent disease not in the registry who learned of our study were also allowed to participate after consent. Dent disease 1 was confirmed by pathogenic mutations of the CLCN5 gene. Dent disease 2 was confirmed by pathogenic mutations of OCRL1. Patients considered to have Dent disease of nontype 1 or 2 had marked LMWP and nephrocalcinosis or hypercalciuria with no identifiable secondary causes but were negative on testing for mutations of CLCN5 and OCRL1.

General information, clinical manifestations, and laboratory results, including serum creatinine and 24-hour urine protein, were abstracted from the RKSC Registry data. Renal function was assessed by serum creatinine values to estimate GFR using the Schwartz equation (13) in children <18 years old and the Modification of Diet in Renal Disease equation (14) in adults. Body surface areas were calculated from height and weight using the Du Bois formula (15). Values obtained nearest to and within 1 year of the biopsy were considered for analysis.

Review of Renal Pathology Reports and Original Slides

Clinical renal pathology reports were reviewed independently by two researchers (X.W. and A.J.M.) to confirm interpretations. Original slides from six patients were collected and reviewed by L.H.H., a board–certified renal pathologist at the Mayo Clinic.

Statistical Methods

Results were expressed in the form of means±SD or medians (25th, 75th percentiles) for continuous variables and percentages for categorical variables. Scatterplots were generated to explore the relationship of age with the percentage of globally sclerotic glomeruli and kidney function. Generalized estimating equation models were fit to assess the association between age and eGFR during follow-up. Linear regression models were used to explore the relationship of the percentage of globally sclerotic glomeruli with tubulointerstitial findings and the relationship of histopathologic characteristics with kidney function both at biopsy and during follow-up. Multivariate models assessed the independence of histopathologic characteristics that associated with kidney function. P values <0.05 were considered to be statistically significant. All statistical analyses were performed using JMP, 10.0 (JMP Statistical Discovery, Cary, NC) or SAS, 9.4 (SAS Institute Inc., Cary, NC).

Results

Study Sample

As of July of 2015, pathology reports from clinical kidney biopsies of 30 boys and men in eight countries performed between 1977 and 2014 were collected. Their demographic and clinical characteristics are shown in Table 1, with the corresponding genetic testing results and biopsy indications shown in Supplemental Table 1. A majority (86%; 26 of 30) were Dent disease 1, whereas 7% (two of 30) were Dent disease 2, and 7% (two of 30) lacked mutations in CLCN5 or OCRL1 (i.e., neither type 1 nor type 2) but met clinical criteria for Dent disease. Median (25th, 75th percentiles) age at biopsy was 7.5 (5, 19) years old, whereas eGFR within 1 year of biopsy was 69 (44, 94) ml/min per 1.73 m2, and 24-hour urine protein was 2000 (1325, 2936) mg. The mean BP (when measured) was 105/61 mmHg, and none of the patients had a history of hypertension at the time of biopsy or during subsequent follow-up. All patients manifest increased excretion of LMWP when assessed (24 of 24), and 80% (20 of 25) had hypercalciuria. Only a minority (18%; five of 28) had a history of kidney stones, and 14% (three of 21) had rickets. Data for urine albumin were not available in the vast majority of patients, but the serum albumin was within the normal range in patients when measured (4.5±0.43 g/dl; n=12). A subset (17%; five of 30) of patients had repeat biopsies; of these, 80% (four of five) were performed for steroid-resistant proteinuria.

View this table:
Table 1.

Characteristics of 30 boys and men with Dent disease at renal biopsy

Renal Histopathologic Features

Biopsy slides were available for six patients with Dent disease 1 for review by a single renal pathologist (L.H.H.). Representative findings are displayed in Figure 1. Prominent features included focal global glomerulosclerosis and interstitial fibrosis. Notably absent were features to suggest focal segmental sclerosis or glomerular inflammation. Interstitial inflammation was noted only adjacent to sclerotic glomeruli. Nephrocalcinosis was detected in two patients, but it was only prominent in areas of those biopsies that happened to be near the corticomedullary junction.

Figure 1.
Figure 1.

Renal histopathologic features in Dent disease 1. (A) Glomeruli with global sclerosis (arrows) and intact glomerulus (star). Silver (×1000). (B) Tubulitis (arrow). Periodic–acid Schiff (×1000). (C) Globally sclerotic glomerulus adjacent to the interstitium with lymphocytes infiltration (arrow) and intact glomeruli (stars). Masson Trichrome (×2000). (D) Calcium phosphate crystals in the tubule (arrow) and interstitium (star). Von Kossa (×1000).

Major histopathologic findings from the clinical renal pathology reports are listed in Table 2. Focal global glomerulosclerosis (a representative example is in Figure 1A) was reported in 83% of patients, with the median (25th, 75th percentiles) percentage of globally sclerotic glomeruli of 9.5% (2.2%, 24.3%). FSGS was documented in only 7% (two of 30), although FSGS was still reported as suspected in 17% (five of 30). Focal segmental glomerular capillary collapse was reported in two other patients (7%) who had no evidence of FSGS.

View this table:
Table 2.

Renal histopathologic findings among 30 boys and men with Dent disease

Foot process effacement was noted in 57% of the patients (13 of 23), but it was segmental in all patients (13 of 13) and mild in the vast majority (12 of 13) (Table 2). The glomerular basement membrane was normal in the majority (85%; 17 of 20), with slightly thickened or thin basement membranes reported in only 10% (two of 20) and 5% (one of 20), respectively. Other infrequent glomerular findings included mild mesangial hypercellularity (13.3%; four of 30), cellular crescents (3.3%; one of 30), cystic transformation with dilation of the glomerular urinary space and embryonic structure (3.3%; one of 30), and mild to moderate thickening of Bowman’s capsule (3.3%; one of 30). Immunofluorescence staining was negative or nonspecific in all patients.

As shown in Table 2, the main tubulointerstitial findings were focal interstitial fibrosis (60%; 18 of 30), interstitial lymphocytic infiltration (53.3%; 16 of 30), and tubular damage (70%; 21 of 30), including tubular atrophy, tubular dilation, or tubulitis (a representative example is in Figure 1B). The severity of these lesions was mild in the vast majority of patients. As shown by the example in Figure 1C, interstitial fibrosis and inflammation were located adjacent to a sclerotic glomeruli in three patients, whereas in 27 pathology reports, fibrosis and/or inflammation were mentioned, but the distribution was not described. Presence of a higher proportion of globally sclerotic glomeruli was associated with interstitial fibrosis, interstitial inflammation, and tubular damage (Table 3). Other infrequent tubulointerstitial findings included focal giant mitochondria with dense condensation in proximal tubular epithelial cells in one patient and dilation of the endoplasmic reticulum in the proximal tubules in another patient (noted by electron microscopy). Blood vessels were unremarkable in the majority of patients (88%; 22 of 25), with mild vascular smooth muscle hypertrophy or hyperplasticity in a minority of patients (12%; three of 25).

View this table:
Table 3.

Univariate associations of tubulointerstitial findings with proportion of globally sclerotic glomeruli

Nephrocalcinosis was only reported in 20% (six of 30). As shown in Figure 1D, the nephrocalcinosis was present in either the interstitium or the lumen of distal tubules or collecting ducts. Because of the limited number of samples that had specific staining for calcium, statistical analyses were not performed to assess the association of nephrocalcinosis with tubulointerstitial features. However, it is notable that tubular damage was reported in the vast majority of patients (five of six) with histopathologic nephrocalcinosis.

Renal Pathology and Kidney Function Progress with Age

As shown in Figure 2A, older age at biopsy was associated with a higher percentage of globally sclerotic glomeruli (P<0.001). The percentage of globally sclerotic glomeruli was generally much higher than the published proportion in healthy age–matched living kidney donors and/or autopsied human kidneys (Figure 2A, Supplemental Table 1) (16,17). Interstitial inflammation and tubular damage were more likely to be present in older patients with Dent disease (P=0.04 and P=0.05, respectively). Two patients had initial biopsies at ages 4 and 5 years old, with subsequent biopsies for steroid-resistant proteinuria 15 and 32 months later, respectively. The percentage of globally sclerotic glomeruli increased from 0% to 11% in the first patient and from 15% to 17% in the second patient, respectively.

Figure 2.
Figure 2.

Older age at biopsy was associated with higher percentage of globally sclerotic glomeruli and lower kidney function. (A) Association of age at biopsy with percentage of globally sclerotic glomeruli (solid line; P<0.001). Age–matched estimated percentage of globally sclerotic glomeruli (line with stars) was generated using the 95% upper limit of globally sclerotic glomeruli present in a large cohort of healthy living kidney donors (on the basis of an average of 16 glomeruli per biopsy) (16). (B) Association of age at biopsy with eGFR (P<0.01).

As shown in Figure 2B, older age at biopsy was associated with lower eGFR (P<0.01). In Figure 3, 18 patients had multiple follow-up visits with a median period of follow-up of 3 (1, 7) years. During follow-up, average eGFR decline was −2.21 (95% confidence interval, −3.03 to −1.37) ml/min per 1.73 m2 per year (P<0.001).

Figure 3.
Figure 3.

eGFR decline during follow up. Plot of age and eGFR at follow-up visits for 18 patients.

Association of Renal Histopathologic Features with Kidney Function

As shown in Table 4, in a univariate model, a higher percentage of globally sclerotic glomeruli, interstitial inflammation, and foot process effacement was associated with a lower eGFR at biopsy. In a multivariate model (including percentages of globally sclerotic glomeruli, interstitial inflammation, foot process effacement, and age), the association of foot process effacement at biopsy and eGFR remained (Table 4). Higher 24-hour urinary protein was associated with lower eGFR at biopsy (P=0.003) and higher percentage of globally sclerotic glomeruli (P=0.01) but not interstitial fibrosis, interstitial inflammation, tubular damage, nephrocalcinosis, and foot process effacement. These associations persisted after adjustment for body surface area (P=0.01 and P=0.04, respectively). As shown in Table 5, the presence of foot process effacement was associated with a steeper annual eGFR decline during follow-up after biopsy but not associated with the percentage of globally sclerotic glomeruli or the presence of interstitial fibrosis, interstitial inflammation, tubular damage, or nephrocalcinosis. This association persisted after adjustment for age.

View this table:
Table 4.

Associations of histopathologic characteristics with kidney function at biopsy

View this table:
Table 5.

Associations of histopathologic characteristics with annual change in eGFR during follow-up among 18 patients with follow-up data available

Repeat analysis was performed after excluding two patients who did not have Dent disease 1 or Dent disease 2. The associations of histopathologic features with age and kidney function did not significantly change. Focal global glomerulosclerosis was also present in patients with Dent disease 2 or Dent disease nontype 1 or 2 (Supplemental Table 1).

Discussion

In this study, focal global glomerulosclerosis was present in the large majority of patients with Dent disease. The percentage of globally sclerotic glomeruli was strongly associated with kidney function and age at the time of biopsy. Indeed, the percentage of globally sclerotic glomeruli among adults was far in excess of that expected for age; equally robust reference ranges are not available for the pediatric age range. Foot process effacement was also associated with eGFR both at the time of biopsy and during subsequent follow-up, but it was mild and segmental. It is notable that global glomerulosclorosis was associated with kidney function at the time of biopsy but not associated with it during the follow-up. This observation might suggest that global glomerulosclorosis is the final step/downstream of the process of glomerular injury, whereas foot process effacement is an early step/upstream of this injury. The presence of foot process effacement at biopsy may suggest that injury is ongoing in the glomeruli, which could lead to a continuous decline in kidney function over follow-up. Evidence for tubular injury and the presence of interstitial fibrosis and inflammation were also observed along with microscopic nephrocalcinosis but only when the biopsy contained corticomedullary tissue. These results show that glomerular pathology is common and associated with declining kidney function in this inherited disorder, generally believed to be a disease primarily of tubules. One unanswered question is whether global glomerulosclerosis is entirely secondary to tubular injury or if podocyte dysfunction also plays a role.

The tubular dysfunction of Dent disease is well described along with the associated clinical manifestations of LMWP, hypercalciuria, nephrolithiasis, CKD, and hyperphosphaturia (8,18). Several features have been attributed to impaired proximal tubular endocytosis (19,20). Indeed, it has been documented that CLC-5–deficient male mice develop most of the manifestations of Dent disease and have in vivo defects of proximal tubular endocytosis because of the lack of ClC-5 protein within early endosomes (20). In addition, studies have shown that endocytosis in the pronephric tubule is impaired in OCRL1–deficient zebrafish embryos (21). Early studies using immunohistochemistry revealed that ClC-5 was expressed in the epithelial cells lining the proximal tubules and the thick ascending limbs of the loop of Henle and in the intercalated cells of the collecting ducts (9). Recent immunolocalization studies have also shown that ClC-5 is present in podocyte foot processes of patients without Dent disease (10). Furthermore, Podocyte ClC-5 overexpression was observed in biopsies from proteinuric patients with diabetes and IgA nephropathy, suggesting the possibility of podocyte protein endocytosis (10). In fact, glomerular podocyte vacuolization has been observed by others in renal biopsies from severely proteinuric patients (10,22). In our study, podocyte foot process effacement was commonly seen in patients with Dent disease, and it was associated with impaired kidney function. However, the degree of foot process effacement was mild and segmental. Overall, it remains possible that the podocyte may actively rather than passively be involved in the process of global glomerulosclerosis associated with Dent disease, and further studies are needed.

In this study, tubulointerstitial injury was commonly present and associated with the proportion of globally sclerotic glomeruli; in some patients, it was also observed adjacent to sclerotic glomeruli. These findings may be consistent with our hypothesis that the glomerulosclerosis might be the result of the combination of primary podocyte injury and reaction secondary to tubulointerstitial lesions.

Another important finding in this study is that a trial of steroid and immunosuppressive treatment was not uncommon because of a suspicion of FSGS, which was on the basis of the combination of focal global glomerulosclerosis and absence of severe tubulointerstitial damage. In addition, several patients in this study as well as previously reported patients (7,23) had a repeat kidney biopsy caused by steroid-resistant proteinuria. Such patients illustrate that wider appreciation of the pathologic features of Dent disease may be crucial to allow an early and correct diagnosis and avoid unnecessary and potentially harmful treatments. In practice, biopsies from proteinuric boys and men that reveal focal global glomerulosclerosis and mild segmental foot process effacement should at least raise suspicion of Dent disease and trigger a screen for urinary LMWP and consideration of genetic testing.

A recent study described that the urinary proteome of patients with Dent disease was enriched with proteins actively involved in interstitial matrix remodeling, including TIM1, TIM2, and MMP9 (24). This combination suggests activation of profibrotic pathways. Although the primary trigger is not currently known, antifibrotic drugs might potentially be beneficial. Nephrocalcinosis has been reported as an important feature of Dent disease of both types (8,25–27). In this study, only a minority had microscopic nephrocalcinosis. However, most percutaneous renal biopsies do not include corticomedullary tissue, the site of nephrocalcinosis in Dent disease. How does the nephrocalcinosis arise in Dent disease? The degree of hypercalciuria is not necessarily marked. Could the interstitial fibrosis be a response to interstitial crystals or signal release by cells in response to crystals? Could the defects in endocytosis lead to abnormal cellular processing of crystals that adhere and are internalized? Could the apical expression of adhesion molecules be upregulated? Many questions remain to be answered.

Limitations of this study include the relatively small size of the cohort, although currently, this is the largest reported collection of patient biopsy data for this rare genetic disease. In addition, certain laboratory characteristics, such as urinary albumin levels, were only available in a minority of the patients, thereby limiting statistical analysis. Although some clinical features may vary among patients from different backgrounds, the critical phenotypes (elevated LMWP and impaired kidney function) were consistent between this study and others in the literature (Supplemental Table 2, 28–31). However, biopsy selection bias may exist, because patients with a CKD phenotype and possibly, older patients may have been biopsied more frequently than patients without CKD and/or with typical tubular presentation. The numbers of patients with follow-up renal function data were somewhat limited, and among these, the fall in eGFR, in general, is rather steep (Figure 3). Thus, the power to detect predictors of GFR decline after biopsy may have been limited. The pathologic features were also analyzed primarily by review of official pathology reports, because slides were available for direct review by the authors for only a small subset of the patients. However, the consistency of pathologic findings reported by different pathologists from different facilities combined with the findings in the reports matching those observed on the actual slides when available were convincing evidence that the pathology reports in this study were reliable.

In summary, this study shows that focal global glomerulosclerosis is common in Dent disease, particularly among older patients and those with lower eGFR. Foot process effacement was frequently observed, and it was associated with kidney function at the time of biopsy and during follow-up but mild and segmental. Nevertheless, glomerular pathology specifically involving podocytes, because of the lack of ClC-5 protein, may play a role in the progression of renal disease. The marked glomerulosclerosis may also result from a maladaptive response to the ongoing tubulointerstitial injury. However, further studies are needed to test this hypothesis and investigate the underlying mechanisms that may lead to the disclosure of new therapeutic targets for Dent disease.

Disclosures

None.

Acknowledgments

We thank Alicia Meek for her assistance in data collection.

This study was supported by Rare Kidney Stone Consortium grant U54KD083908, a part of the Rare Diseases Clinical Research Network, an initiative of the Office of Rare Diseases Research, the National Center for Advancing Translational Sciences (NCATS). This consortium is funded through a collaboration between the NCATS and the National Institute of Diabetes and Digestive and Kidney Diseases.

The study sponsor had no role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication.

Footnotes

  • Received April 1, 2016.
  • Accepted August 16, 2016.

References

  1. ↵
    1. Dent CE,
    2. Friedman M
    : Hypercalcuric rickets associated with renal tubular damage. Arch Dis Child 39: 240–249, 1964pmid:14169453
    OpenUrlFREE Full Text
  2. ↵
    1. Pagon RA,
    2. Adam MP,
    3. Ardinger HH,
    4. Wallace SE,
    5. Amemiya A,
    6. Bean LJH,
    7. Bird TD,
    8. Fong CT,
    9. Mefford HC,
    10. Smith RJH,
    11. Stephens K
    1. Lieske JC,
    2. Milliner DS,
    3. Beara-Lasic L,
    4. Harris P,
    5. Hopp K,
    6. Cogal A,
    7. Mattison K
    : Dent Disease. In: GeneReviews, edited by Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, Seattle, WA, University of Washington, 1993
  3. ↵
    1. Scheinman SJ
    : X-linked hypercalciuric nephrolithiasis: Clinical syndromes and chloride channel mutations. Kidney Int 53: 3–17, 1998pmid:9452994
    OpenUrlCrossRefPubMed
  4. ↵
    1. Ludwig M,
    2. Utsch B,
    3. Monnens LA
    : Recent advances in understanding the clinical and genetic heterogeneity of Dent’s disease. Nephrol Dial Transplant 21: 2708–2717, 2006pmid:16861240
    OpenUrlFREE Full Text
  5. ↵
    1. Frymoyer PA,
    2. Scheinman SJ,
    3. Dunham PB,
    4. Jones DB,
    5. Hueber P,
    6. Schroeder ET
    : X-linked recessive nephrolithiasis with renal failure. N Engl J Med 325: 681–686, 1991pmid:1908057
    OpenUrlCrossRefPubMed
  6. ↵
    1. Gambaro G,
    2. Vezzoli G,
    3. Casari G,
    4. Rampoldi L,
    5. D’Angelo A,
    6. Borghi L
    : Genetics of hypercalciuria and calcium nephrolithiasis: From the rare monogenic to the common polygenic forms. Am J Kidney Dis 44: 963–986, 2004pmid:15558518
    OpenUrlCrossRefPubMed
  7. ↵
    1. Fervenza FC
    : A patient with nephrotic-range proteinuria and focal global glomerulosclerosis. Clin J Am Soc Nephrol 8: 1979–1987, 2013pmid:23886564
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Wrong OM, Norden AG, Feest TG: Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87: 473–493, 1994
  9. ↵
    1. Devuyst O,
    2. Christie PT,
    3. Courtoy PJ,
    4. Beauwens R,
    5. Thakker RV
    : Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent’s disease. Hum Mol Genet 8: 247–257, 1999pmid:9931332
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Ceol M,
    2. Tiralongo E,
    3. Baelde HJ,
    4. Vianello D,
    5. Betto G,
    6. Marangelli A,
    7. Bonfante L,
    8. Valente M,
    9. Della Barbera M,
    10. D’Angelo A,
    11. Anglani F,
    12. Del Prete D
    : Involvement of the tubular ClC-type exchanger ClC-5 in glomeruli of human proteinuric nephropathies. PLoS One 7: e45605, 2012pmid:23029130
    OpenUrlCrossRefPubMed
  11. ↵
    1. Frishberg Y,
    2. Dinour D,
    3. Belostotsky R,
    4. Becker-Cohen R,
    5. Rinat C,
    6. Feinstein S,
    7. Navon-Elkan P,
    8. Ben-Shalom E
    : Dent’s disease manifesting as focal glomerulosclerosis: Is it the tip of the iceberg? Pediatr Nephrol 24: 2369–2373, 2009pmid:19806368
    OpenUrlCrossRefPubMed
  12. ↵
    1. Copelovitch L,
    2. Nash MA,
    3. Kaplan BS
    : Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol 2: 914–918, 2007pmid:17702731
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Lemley KV
    : Pediatric nephrology: Estimating GFR in children: Schwartz redux. Nat Rev Nephrol 5: 310–311, 2009pmid:19474825
    OpenUrlCrossRefPubMed
  14. ↵
    1. Levey AS,
    2. Bosch JP,
    3. Lewis JB,
    4. Greene T,
    5. Rogers N,
    6. Roth D; Modification of Diet in Renal Disease Study Group
    : A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461–470, 1999pmid:10075613
    OpenUrlCrossRefPubMed
  15. ↵
    1. Du Bois D,
    2. Du Bois EF
    : A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5: 303–311, 1989pmid:2520314
    OpenUrlPubMed
  16. ↵
    Kremers WK, Denic A, Lieske JC, Alexander MP, Kaushik V, Elsherbiny HE, Chakkera HA, Poggio ED, Rule AD: Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: The Aging Kidney Anatomy study. Nephrol Dial Transplant 30: 2034–2039, 2015
  17. ↵
    1. Kaplan C,
    2. Pasternack B,
    3. Shah H,
    4. Gallo G
    : Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 80: 227–234, 1975pmid:51591
    OpenUrlPubMed
  18. ↵
    1. Devuyst O,
    2. Thakker RV
    : Dent’s disease. Orphanet J Rare Dis 5: 28, 2010pmid:20946626
    OpenUrlCrossRefPubMed
  19. ↵
    1. Christensen EI,
    2. Devuyst O,
    3. Dom G,
    4. Nielsen R,
    5. Van der Smissen P,
    6. Verroust P,
    7. Leruth M,
    8. Guggino WB,
    9. Courtoy PJ
    : Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci U S A 100: 8472–8477, 2003pmid:12815097
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Piwon N,
    2. Günther W,
    3. Schwake M,
    4. Bösl MR,
    5. Jentsch TJ
    : ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent’s disease. Nature 408: 369–373, 2000pmid:11099045
    OpenUrlCrossRefPubMed
  21. ↵
    1. Oltrabella F,
    2. Pietka G,
    3. Ramirez IB,
    4. Mironov A,
    5. Starborg T,
    6. Drummond IA,
    7. Hinchliffe KA,
    8. Lowe M
    : The Lowe syndrome protein OCRL1 is required for endocytosis in the zebrafish pronephric tubule. PLoS Genet 11: e1005058, 2015pmid:25838181
    OpenUrlCrossRefPubMed
  22. ↵
    1. Yoshikawa N,
    2. Ito H,
    3. Akamatsu R,
    4. Hazikano H,
    5. Okada S,
    6. Matsuo T
    : Glomerular podocyte vacuolation in focal segmental glomerulosclerosis. Arch Pathol Lab Med 110: 394–398, 1986pmid:3754422
    OpenUrlPubMed
  23. ↵
    1. Valina MR,
    2. Larsen CP,
    3. Kanosky S,
    4. Suchy SF,
    5. Nield LS,
    6. Onder AM
    : A novel CLCN5 mutation in a boy with asymptomatic proteinuria and focal global glomerulosclerosis. Clin Nephrol 80: 377–384, 2013pmid:22735364
    OpenUrlCrossRefPubMed
  24. ↵
    1. Santucci L,
    2. Candiano G,
    3. Anglani F,
    4. Bruschi M,
    5. Tosetto E,
    6. Cremasco D,
    7. Murer L,
    8. D’Ambrosio C,
    9. Scaloni A,
    10. Petretto A,
    11. Caridi G,
    12. Rossi R,
    13. Bonanni A,
    14. Ghiggeri GM
    : Urine proteome analysis in Dent’s disease shows high selective changes potentially involved in chronic renal damage. J Proteomics 130: 26–32, 2016pmid:26370164
    OpenUrlCrossRefPubMed
  25. ↵
    1. Szczepanska M,
    2. Zaniew M,
    3. Recker F,
    4. Mizerska-Wasiak M,
    5. Zaluska-Lesniewska I,
    6. Kilis-Pstrusinska K,
    7. Adamczyk P,
    8. Zawadzki J,
    9. Pawlaczyk K,
    10. Ludwig M,
    11. Sikora P
    : Dent disease in children: Diagnostic and therapeutic considerations. Clin Nephrol 84: 222–230, 2015pmid:26308078
    OpenUrlPubMed
    1. De Mutiis C,
    2. Pasini A,
    3. La Scola C,
    4. Pugliese F,
    5. Montini G
    : Nephrotic-range Albuminuria as the presenting symptom of Dent-2 disease. Ital J Pediatr 41: 46, 2015pmid:26108450
    OpenUrlCrossRefPubMed
  27. ↵
    1. Sekine T,
    2. Komoda F,
    3. Miura K,
    4. Takita J,
    5. Shimadzu M,
    6. Matsuyama T,
    7. Ashida A,
    8. Igarashi T
    : Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA: Genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria. Nephrol Dial Transplant 29: 376–384, 2014pmid:24081861
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Tosetto E,
    2. Ghiggeri GM,
    3. Emma F,
    4. Barbano G,
    5. Carrea A,
    6. Vezzoli G,
    7. Torregrossa R,
    8. Cara M,
    9. Ripanti G,
    10. Ammenti A,
    11. Peruzzi L,
    12. Murer L,
    13. Ratsch IM,
    14. Citron L,
    15. Gambaro G,
    16. D’angelo A,
    17. Anglani F
    : Phenotypic and genetic heterogeneity in Dent’s disease--the results of an Italian collaborative study. Nephrol Dial Transplant 21: 2452–2463, 2006pmid:16822791
    OpenUrlAbstract/FREE Full Text
    1. Dinour D,
    2. Davidovitz M,
    3. Levin-Iaina N,
    4. Lotan D,
    5. Cleper R,
    6. Weissman I,
    7. Knecht A,
    8. Holtzman EJ
    : Truncating mutations in the chloride/proton ClC-5 antiporter gene in Seven Jewish Israeli families with Dent’s 1 disease. Nephron Clin Pract 112: c262–c267, 2009pmid:19546586
    OpenUrlCrossRefPubMed
    1. Carballo-Trujillo I,
    2. Garcia-Nieto V,
    3. Moya-Angeler FJ,
    4. Antón-Gamero M,
    5. Loris C,
    6. Méndez-Alvarez S,
    7. Claverie-Martin F
    : Novel truncating mutations in the ClC-5 chloride channel gene in patients with Dent’s disease. Nephrol Dial Transplant 18: 717–723, 2003pmid:12637640
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Li F,
    2. Yue Z,
    3. Xu T,
    4. Chen M,
    5. Zhong L,
    6. Liu T,
    7. Jing X,
    8. Deng J,
    9. Hu B,
    10. Liu Y,
    11. Wang H,
    12. Lai KN,
    13. Sun L,
    14. Liu J,
    15. Maxwell PH,
    16. Wang Y
    : Dent disease in Chinese Children and findings from heterozygous mothers: Phenotypic heterogeneity, fetal growth, and 10 novel mutations. J Pediatr 174: 204–210.e1, 2016pmid:27174143
    OpenUrlCrossRefPubMed
View Abstract
Back to top

In this issue

View Selected Citations (0)
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Request Permissions
Glomerular Pathology in Dent Disease and Its Association with Kidney Function
Xiangling Wang, Franca Anglani, Lada Beara-Lasic, Anila J. Mehta, Lisa E. Vaughan, Loren Herrera Hernandez, Andrea Cogal, Steven J. Scheinman, Gema Ariceta, Robert Isom, Lawrence Copelovitch, Felicity T. Enders, Dorella Del Prete, Giuseppe Vezzoli, Fabio Paglialonga, Peter C. Harris, John C. Lieske
CJASN Dec 2016, 11 (12) 2168-2176; DOI: 10.2215/CJN.03710416
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Keywords